Danilov AV, Flinn IW, Davids MS, Gregory B, Bentur O, Sidransky D, Brown JR. The phase III DUO trial of PI3K inhibitor duvelisib <i>versus</i&gt; ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival. Haematologica 2024;109(10):3379-3382; https://doi.org/10.3324/haematol.2024.285043.